These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 18176602)

  • 21. Recent insights into the structure of Toll-like receptors and post-translational modifications of their associated signalling proteins.
    Carpenter S; O'Neill LA
    Biochem J; 2009 Jul; 422(1):1-10. PubMed ID: 19627256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cross-talk among Toll-like receptors and their ligands.
    Palazzo M; Gariboldi S; Zanobbio L; Dusio GF; Selleri S; Bedoni M; Balsari A; Rumio C
    Int Immunol; 2008 May; 20(5):709-18. PubMed ID: 18397908
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic applications of nucleic acids as ligands for Toll-like receptors.
    Panter G; Kuznik A; Jerala R
    Curr Opin Mol Ther; 2009 Apr; 11(2):133-45. PubMed ID: 19330719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of signaling pathways involved in peptidoglycan-induced RANTES production from murine Langerhans cells.
    Matsui K; Wirotesangthong M; Nishikawa A
    Int Arch Allergy Immunol; 2009; 149(2):167-72. PubMed ID: 19127075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired cytokine response in myeloid dendritic cells in chronic hepatitis C virus infection regardless of enhanced expression of Toll-like receptors and retinoic acid inducible gene-I.
    Miyazaki M; Kanto T; Inoue M; Itose I; Miyatake H; Sakakibara M; Yakushijin T; Kakita N; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    J Med Virol; 2008 Jun; 80(6):980-8. PubMed ID: 18428149
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
    Schmitt A; Li L; Giannopoulos K; Greiner J; Reinhardt P; Wiesneth M; Schmitt M
    Transfusion; 2008 May; 48(5):861-70. PubMed ID: 18208411
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells.
    Mäkelä SM; Strengell M; Pietilä TE; Osterlund P; Julkunen I
    J Leukoc Biol; 2009 Apr; 85(4):664-72. PubMed ID: 19164128
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Innate immunity and adipocyte function: ligand-specific activation of multiple Toll-like receptors modulates cytokine, adipokine, and chemokine secretion in adipocytes.
    Kopp A; Buechler C; Neumeier M; Weigert J; Aslanidis C; Schölmerich J; Schäffler A
    Obesity (Silver Spring); 2009 Apr; 17(4):648-56. PubMed ID: 19148127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential induction of MyD88- and TRIF-dependent pathways in equine monocytes by Toll-like receptor agonists.
    Figueiredo MD; Vandenplas ML; Hurley DJ; Moore JN
    Vet Immunol Immunopathol; 2009 Jan; 127(1-2):125-34. PubMed ID: 19019456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toll-like receptors in the CNS: implications for neurodegeneration and repair.
    van Noort JM; Bsibsi M
    Prog Brain Res; 2009; 175():139-48. PubMed ID: 19660653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction.
    O'Neill LA
    Immunity; 2008 Jul; 29(1):12-20. PubMed ID: 18631453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heat shock proteins and toll-like receptors.
    Asea A
    Handb Exp Pharmacol; 2008; (183):111-27. PubMed ID: 18071657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and activity of Toll-like receptors 1-9 in the human term placenta and changes associated with labor at term.
    Patni S; Wynen LP; Seager AL; Morgan G; White JO; Thornton CA
    Biol Reprod; 2009 Feb; 80(2):243-8. PubMed ID: 18815357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ampligen: a potential toll-like 3 receptor adjuvant for immunotherapy of cancer.
    Jasani B; Navabi H; Adams M
    Vaccine; 2009 May; 27(25-26):3401-4. PubMed ID: 19200817
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticancer TLR agonists on the ropes.
    Guha M
    Nat Rev Drug Discov; 2012 Jun; 11(7):503-5. PubMed ID: 22743965
    [No Abstract]   [Full Text] [Related]  

  • 36. Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis.
    Ospelt C; Brentano F; Rengel Y; Stanczyk J; Kolling C; Tak PP; Gay RE; Gay S; Kyburz D
    Arthritis Rheum; 2008 Dec; 58(12):3684-92. PubMed ID: 19035519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunostimulatory activity of Toll-like receptor 8 agonists towards human leucocytes: basic mechanisms and translational opportunities.
    Philbin VJ; Levy O
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1485-91. PubMed ID: 18031250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variants in the toll-like receptor signaling pathway and clinical outcomes of malaria.
    Leoratti FM; Farias L; Alves FP; Suarez-Mútis MC; Coura JR; Kalil J; Camargo EP; Moraes SL; Ramasawmy R
    J Infect Dis; 2008 Sep; 198(5):772-80. PubMed ID: 18662133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential regulation of toll-like receptor mRNAs in amyloid plaque-associated brain tissue of aged APP23 transgenic mice.
    Frank S; Copanaki E; Burbach GJ; Müller UC; Deller T
    Neurosci Lett; 2009 Mar; 453(1):41-4. PubMed ID: 19429012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toll-like receptors and agonist responses in the developing fetal sheep lung.
    Hillman NH; Moss TJ; Nitsos I; Kramer BW; Bachurski CJ; Ikegami M; Jobe AH; Kallapur SG
    Pediatr Res; 2008 Apr; 63(4):388-93. PubMed ID: 18356744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.